European Management of Glanzmann’s Thrombasthenia from EAHAD’s Working Group
European Association for Haemophilia and Allied Disorders (EAHAD) shared on LinkedIn:
”Care for Glanzmann’s thrombasthenia still varies widely across Europe, from antibody screening practices to access to HLA-matched platelets.
A new publication from the EAHAD Glanzmann Thrombasthenia Working Group highlights areas of agreement and where further alignment is needed.
Read more on the Haemophilia Journal.”
Read the full article in Haemophilia Journal.
Article: European Management of Glanzmann’s Thrombasthenia: A Survey of Current Clinical Practice
Authors: Mathieu Fiore, Andrea Artoni, Robert Klamroth, Mary Mathias, Roger Schutgens, Roseline d’Oiron, EAHAD Glanzmann Thrombasthenia Working Group
Stay updated on all scientific advances in the field of platelet disorders with Hemostasis Today.
-
Jul 12, 2026, 08:50Where the Hemophilia Community Comes Together at ISTH 2026 – EAHAD
-
Jul 12, 2026, 08:2210 Posts Not To Miss from ISTH 2026, Part 1
-
Jul 12, 2026, 07:58Brian O Mahony: Could NXT-007 Minimize the Need for Perioperative FVIII
-
Jul 12, 2026, 07:50Shayan Mohammadmoradi: Connecting the Next Generation of Hemostasis Researchers at ISTH 2026
-
Jul 12, 2026, 07:42Alexandra Yakusheva: ThrombInnov Debuts at ISTH 2026 with a Focus on Translational Research
-
Jul 12, 2026, 07:34Wolfgang Miesbach: ISTH 2026 Explores the Next Generation of APS Diagnostics
-
Jul 12, 2026, 07:28Sara Zalghout: ISTH 2026 Highlights Progress in Thromboinflammation Research
-
Jul 12, 2026, 07:13Ekaterina Balaian: Finding Healing Through Art at ISTH 2026
-
Jul 12, 2026, 06:59Maaike Sybil Jongen: Flow Cytometry for Platelet Phenotyping at ISTH 2026